Arthur Wong
Arthur Wong is the managing director for US health care practice at S&P Global. He has expressed concerns that the tariffs on pharmaceutical imports could ultimately burden consumers and patients, as the increased costs may lead to higher prices and limited availability of generic medications.
Global Media Ratings
Countries Mentioned
| Country | Mentions | Sentiment | Dominance | + Persistence | x Population | = Reach | x GDP (millions) | = Power |
|---|---|---|---|---|---|---|---|---|
| United States | 1 | 5.00 | 0.02% | +0% | 331,002,651 | 73,166 | $21,000,000 | 4,642$ |
| Totals | 1 | 331,002,651 | 73,166 | $21,000,000 | 4,642$ |
Interactive World Map
Each country's color is based on "Mentions" from the table above.
Recent Mentions
United States:
Arthur Wong, managing director for US health care practice at S&P Global, stated that the pain will ultimately be borne by the consumer.
5